Skip to main content
. 2018 Nov 10;40(4):1253–1263. doi: 10.1002/hbm.24444

Table 1.

Demographic and clinical features

PD HC Statistics p value
Sample size (M/F) 29/28 20/32 1.69 .19a
Age (years) 59.5 ± 1.21 60.6 ± 1.22 0.61 .54b
Education (years) 8.4 ± 0.66 9.3 ± 0.56 1.08 .28b
Duration (years) 4.6 ± 0.61 NA NA NA
UPDRS‐III 25 ± 1.41 (n = 55)* NA NA NA
H‐Y 1.3 ± 0.35 (n = 50)* NA NA NA
MMSE 28.1 ± 0.32 28.4 ± 0.21 0.90 .36b
MoCA 23.7 ± 0.73 (n = 54)* 25.5 ± 0.62 (n = 32)* 1.70 .10b
VFT 16.5 ± 0.62 (n = 51)* 17.9 ± 0.57 (n = 49)* 1.67 .10b
DST (forward) 7.2 ± 0.23 (n = 49)* 6.9 ± 0.21 (n = 48)* 0.87 .39b
DST (backward) 4.4 ± 0.37 (n = 49)* 4.7 ± 0.23 (n = 48)* 0.68 .50b

Data are mean ± SE. aChi‐square test; btwo‐sample t test.

Abbreviations: DST = Digit Span Test; F = Female; HC = Healthy Control; M = Male; MoCA = Montreal Cognitive Assessment; NA = Not Available; PD = Parkinson's Disease; UPDRS = Unified Parkinson's Disease Rating Scale; VFT = Verbal Fluency Test; H‐Y = Hoehn and Yahr stage.

*

Data in parentheses indicates the number of subjects in each test. Data without an asterisk is computed on all subjects.